Schizophrenia & Other Psychotic Disorders
Savvy Psychopharmacology
Lithium-induced bradycardia: A rare but serious adverse effect
This case demonstrates the importance of regular vital sign measurements to be able to detect the incidence of bradycardia, which is a rare but...
Conference Coverage
Lumateperone shows broad phase 3 potential for psychiatric disorders
PARIS – The drug maker plans to submit a New Drug Application to the Food and Drug Administration for treatment of schizophrenia by mid-2018.
Conference Coverage
In high-risk patients, methylation strikes genes before psychosis hits
BERLIN – Biomarkers are needed for better prediction, staging, and differential diagnosis, Dr. Marie-Odile Krebs says.
Conference Coverage
Physical inactivity in youth is an independent risk factor for schizophrenia
PARIS – Nonparticipation in organized sports tied to 4.88-fold increased risk of developing the disorder.
Conference Coverage
Evenamide impresses for schizophrenia
PARIS – The selective glutamate modulator appears to avoid dopaminergic side effects, multicenter study shows.
Evidence-Based Reviews
Prescribing antipsychotics in geriatric patients: Focus on schizophrenia and bipolar disorder
Antipsychotics are FDA-approved as a primary treatment for schizophrenia and bipolar disorder and as adjunctive therapy for major depressive...
Savvy Psychopharmacology
When should you consider combining 2 long-acting injectable antipsychotics?
Ms. S, age 39, with a 15-year history of schizophrenia and severe paranoid delusions, is admitted after physically assaulting a staff member at a...
Conference Coverage
Benzodiazepines and antidepressants do not impair cognition in midlife schizophrenia
PARIS – Cumulative lifetime exposure to benzodiazepines and antidepressants in the relatively modest amounts typically prescribed in schizophrenia...
Conference Coverage
Antipsychotics may reduce mortality in schizophrenia
Long-acting injectables provided the greatest mortality benefit in a huge Swedish study.
Article
A call for psychiatrists with clozapine expertise in schizophrenia
The CURESZ Foundation was founded in 2016 to bring hope to people suffering from schizophrenia and those who love and care for them. CURESZ was...
Feature
Palliative care for patients suffering from severe persistent mental illness
Psychiatrists and palliative care specialists say certain patients with severe persistent mental illness deserve more palliative care options.